Stock 300086 HONZ PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Honz Pharmaceutical Co., Ltd.

Equities

300086

CNE100000QM6

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.68 CNY +1.08% Intraday chart for Honz Pharmaceutical Co., Ltd. +6.36% -20.27%
2023 Hainan Yougeng Investment Co., Ltd. agreed to acquire Guangdong Yuanning Pharmaceutical Co.,Ltd. from Honz Pharmaceutical Co., Ltd. for CNY12 million. CI
2023 Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 4,860 2,700 2,367 2,529 3,906 2,799
Enterprise Value (EV) 1 3,865 2,548 2,420 2,918 4,240 3,112
P/E ratio 96.9 x 202 x -89.5 x 270 x 356 x -14.9 x
Yield - 2.5% - 0.36% - -
Capitalization / Revenue 10.1 x 3.06 x 2.35 x 2.74 x 4.67 x 5.22 x
EV / Revenue 8.04 x 2.89 x 2.4 x 3.17 x 5.07 x 5.81 x
EV / EBITDA 47.3 x 28 x 37.8 x 25.1 x 130 x -32.1 x
EV / FCF -20.6 x -14.4 x 11.3 x -8.44 x -17.9 x -166 x
FCF Yield -4.85% -6.97% 8.87% -11.9% -5.59% -0.6%
Price to Book 2.63 x 1.75 x 1.58 x 1.68 x 2.6 x 2.13 x
Nbr of stocks (in thousands) 450,000 450,000 450,000 450,000 450,000 450,000
Reference price 2 10.80 6.000 5.260 5.620 8.680 6.220
Announcement Date 4/23/18 4/28/19 4/27/20 4/23/21 4/6/22 4/24/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 480.8 882.7 1,008 921.6 836.6 535.7
EBITDA 1 81.77 91.09 64.04 116.1 32.54 -97.08
EBIT 1 39.29 35.54 2.787 66.94 -5.366 -146.7
Operating Margin 8.17% 4.03% 0.28% 7.26% -0.64% -27.37%
Earnings before Tax (EBT) 1 62.37 34.14 -18.29 28.76 20.35 -221.5
Net income 1 50.2 13.37 -26.46 9.339 10.99 -187.6
Net margin 10.44% 1.51% -2.62% 1.01% 1.31% -35.01%
EPS 2 0.1115 0.0297 -0.0588 0.0208 0.0244 -0.4169
Free Cash Flow 1 -187.4 -177.5 214.6 -345.9 -236.8 -18.76
FCF margin -38.97% -20.11% 21.28% -37.53% -28.31% -3.5%
FCF Conversion (EBITDA) - - 335.12% - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - 0.1500 - 0.0200 - -
Announcement Date 4/23/18 4/28/19 4/27/20 4/23/21 4/6/22 4/24/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 52.8 389 334 313
Net Cash position 1 995 152 - - - -
Leverage (Debt/EBITDA) - - 0.8242 x 3.356 x 10.26 x -3.224 x
Free Cash Flow 1 -187 -177 215 -346 -237 -18.8
ROE (net income / shareholders' equity) 2.53% 1.18% -1.84% 1.25% 0.67% -13.6%
ROA (Net income/ Total Assets) 1.11% 0.97% 0.08% 1.74% -0.13% -3.86%
Assets 1 4,523 1,376 -33,245 536.6 -8,311 4,858
Book Value Per Share 2 4.110 3.430 3.330 3.340 3.340 2.920
Cash Flow per Share 2 0.2600 0.1900 0.3700 0.5800 0.5800 0.6000
Capex 1 153 292 131 300 220 58.9
Capex / Sales 31.79% 33.04% 12.99% 32.5% 26.29% 10.99%
Announcement Date 4/23/18 4/28/19 4/27/20 4/23/21 4/6/22 4/24/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
HONZ PHARMACEUTICAL CO., LTD. Stock Honz Pharmaceutical Co., Ltd.
-20.27% 291M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300086 Stock
  4. Financials Honz Pharmaceutical Co., Ltd.